Bordetella pertussis and the Importance of Vaccination
Introduction and History
![](/images/thumb/6/63/PHIL_22882_lores.jpg/300px-PHIL_22882_lores.jpg)
By Alexandra White
At right is a sample image insertion. It works for any image uploaded anywhere to MicrobeWiki.
The insertion code consists of:
Double brackets: [[
Filename: download.jpg
Thumbnail status: |thumb|
Pixel size: |300px|
Placement on page: |right|
Legend/credit:
Closed double brackets: ]]
Other examples:
Bold
Italic
Subscript: H2O
Superscript: Fe3+
Sample citations: [1]
[2]
A citation code consists of a hyperlinked reference within "ref" begin and end codes.
To repeat the citation for other statements, the reference needs to have a names: "Cite error: Closing </ref>
missing for <ref>
tag. The disease results in over 50 million cases worldwide per year, with the majority being unvaccinated individuals present in Third World Countries. [Kerr et al. 2000]. B. pertussis is spread through coughing and sneezing and symptoms first appear seven to ten days after infection [WHO]. These symptoms include: fever, runny nose, coughing which develops into a whooping cough, and phenomena [WHO]. Those infected with pertussis are contagious for around three weeks once coughing is displayed as a symptom yet symptoms can last up to eight weeks [WHO].
Bordetella pertussis and Infection Stages
Include some current research, with at least one figure showing data.
Every point of information REQUIRES CITATION using the citation tool shown above.
Italic
![](/images/thumb/2/27/1-s2.0-S1471489207000598-gr1.jpg/300px-1-s2.0-S1471489207000598-gr1.jpg)
B. Pertussis Vaccine History
Include some current research, with at least one figure showing data.
Italic
Vaccine Virulence
Include some current research, with at least one figure showing data.
Why Vaccination?
![](/images/thumb/6/6a/Incidence-graph-age-2018.jpg/300px-Incidence-graph-age-2018.jpg)
Conclusion
References
- ↑ Kerr, J.R. and Matthews, R.C."Bordetella pertussis Infection: Pathogenesis, Diagnosis, Management, and the Role of Protective Immunity." 2000. European Journal of Clinical Microbiology and Infectious Disease 19:77-88.
- ↑ Bartlett et al.: Oncolytic viruses as therapeutic cancer vaccines. Molecular Cancer 2013 12:103.
Authored for BIOL 238 Microbiology, taught by Joan Slonczewski, 2022, Kenyon College